Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Do not call
En
Blue Jet Healthcare Ltd. Share Price
Day's Range
Low
₹544.05
High
₹571.75
Price Summary
| Previous Close | ₹548.45 |
|---|---|
| Day's Range | ₹544.05 - ₹571.75 |
| Open | ₹569.95 |
| 52 Week Range | ₹325.00 - ₹647.80 |
| Volume | 4,49,110 |
| Market Cap | ₹0.01 |
| Previous Close | ₹547.85 |
|---|---|
| Day's Range | ₹544.30 - ₹571.15 |
| Open | ₹571.15 |
| 52 Week Range | ₹325.20 - ₹647.05 |
| Volume | 22,351 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 2,463.14 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.21 |
| Price/Earning (TTM) | 77.91 |
| TTM EPS (₹) | 7.31 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | 27.22 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 56.68 |
| Trade Value ( ₹ in Lacs) | 122.45 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.21 |
| Price/Earning (TTM) | 77.91 |
| TTM EPS (₹) | 7.31 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | 27.22 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 56.68 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1654.81 | 10299.85 |
| Expenses | N/A | N/A |
| PBT | 687.27 | 4060.99 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 521.36 | 3052.03 |
About Blue Jet Healthcare Ltd.
| Founded | 1968 |
|---|---|
| Managing Director | Shiven Akshay Arora |
| NSE Symbol | BLUEJET |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,59,496.64 | 1,907.35 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,94,145.82 | 11,560.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,81,473.50 | 4,782.80 | 3,602.00 - 3,602.00 |
| Laurus Labs Ltd. | 1,28,054.00 | 2,446.20 | 917.95 - 917.95 |
| Lenskart Solutions Ltd. | 1,27,377.05 | 718.95 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,20,925.05 | 8,495.50 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,19,700.46 | 1,205.85 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,14,348.68 | 1,376.90 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,13,988.97 | 1,399.65 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,06,445.85 | 2,634.85 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Blue Jet Healthcare informs about BRSR report
Aster DM Quality Care informs about newspaper publications
Pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aster DM Quality Care has informed that it enclosed copies of the newspaper publications of the unaudited financial results of the Company for the quarter and half year ended 30 September 2026, published on 7 November 2026 in the newspapers: Financial Express; and Andhra Jyothi. The said newspaper clippings are made available on the website of the Company at https://www.asterqualitycare.com/.
The above information is a part of company’s filings submitted to BSE.
Gland Pharma informs about appointment of chief investment officer
Gland Pharma has informed that, Xiao Le has been appointed as the Chief Investment Officer of Gland Pharma International, (‘Gland Singapore’) the Wholly-owned subsidiary of the Company, effective November 09, 2026. Xiao Le will be responsible for exploring various investment opportunities and to improve M&A capability for Gland in the United States of America, China, Singapore and other countries. Xiao Le shall be reporting to the CEO of Gland Singapore. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are given in Annexure-A enclosed.
The above information is a part of company’s filings submitted to BSE.
Morepen Laboratories informs about press release
Morepen Laboratories informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Blue Jet Healthcare Ltd. is ₹548.45 as of 2026-11-09.
The market capitalisation of Blue Jet Healthcare Ltd. is ₹10,783.98 as of 2026-11-08.
The 1-year return of Blue Jet Healthcare Ltd. is -49.70% as of 2026-11-09.
The P/E ratio of Blue Jet Healthcare Ltd. is 22.91 as of 2026-11-09.
The 52-week high and low of Blue Jet Healthcare Ltd. are ₹647.80 and ₹325.00, respectively, as of 2026-11-09.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
